Adjuvant Treatment Strategies in Resectable Non–Small

Switching their focus to the adjuvant setting of resectable NSCLC, expert panelists identify treatment options in this setting and review the clinical data behind them.

Related Keywords

, Recent Updates , Translating Evidence , Clinical Practice , Treatment Strategies , Resectable Non , Small Cell Lung Cancer , Lung Cancer , Non Small Cell Lung Cancer , Nsclc , Trio Therapy , Immunotherapy , Immune Checkpoint Inhibitors , Adjuvant Therapy , Perioperative Therapy , Adjuvant Chemotherapy , Impower010 , Atezolizumab Therapy , Adjuvant Atezolizumab , Keynote 091 , Pembrolizumab , Adjuvant Pembrolizumab , Pdl1 Level , Pdl1 Expression , Pearls Study , Pearls Trial , Path Cr , Pathologic Complete Response ,